Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 T

Authors :: Warnert, E.A.H. (Esther A. H.)
Wood, T.C. (Tobias C.)
Incekara, F. (Fatih)
Barker, G.J. (Gareth J.)
Vincent, A. (Audrey)
Schouten, J.W. (Joost)
Kros, J.M. (Johan)
Bent, M.J. (Martin) van den
Smits, M. (Marion)
Tamames, J.A.H. (Juan A. Hernandez)
Warnert, E.A.H. (Esther A. H.)
Wood, T.C. (Tobias C.)
Incekara, F. (Fatih)
Barker, G.J. (Gareth J.)
Vincent, A. (Audrey)
Schouten, J.W. (Joost)
Kros, J.M. (Johan)
Bent, M.J. (Martin) van den
Smits, M. (Marion)
Tamames, J.A.H. (Juan A. Hernandez)
Publication Year :: 2021
Abstract: Objective: Amide proton transfer (APT) weighted chemical exchange saturation transfer (CEST) imaging is increasingly used to investigate high-grade, enhancing brain tumours. Non-enhancing glioma is currently less studied, but shows heterogeneous pathophysiology with subtypes having equally poor prognosis as enhancing glioma. Here, we investigate the use of CEST MRI to best differentiate non-enhancing glioma from healthy tissue and image tumour heterogeneity. Materials & Methods: A 3D pulsed CEST sequence was applied at 3 Tesla with whole tumour coverage and 31 off-resonance frequencies (+6 to -6 ppm) in 18 patients with non-enhancing glioma. Magnetisation transfer ratio asymmetry (MTRasym) a

Database :: OAIster
Notes :: application/pdf, Magnetic Resonance Materials in Physics, Biology and Medicine, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1244878732
Document Type :: Electronic Resource
Full Text :: https://doi.org/10.1007.s10334-021-00911-6

Full Text Access

Tools